MedPath

Effect of Perioperative Sivelstat Administration for Liver Resection

Not Applicable
Completed
Conditions
Liver Diseases
Interventions
Drug: sivelstat
Registration Number
NCT00738348
Lead Sponsor
Kochi University
Brief Summary

It is reported that sivelstat improved and preserved the postoperative renal function in the orthopedic management. Moreover because sivelstat reduced the migration of neutrophil, it improved acute lung injury. During liver resection, Pringle maneuver, clamping the hepatoduodenal ligament, was performed. Pringle maneuver causes reperfusion injury of the liver. We have a hypothesis that sivelstat prevent the warm shock of reperfusion injury of the liver by Pringle maneuver.

Detailed Description

Whether the incidence of postoperative morbidities, such as liver failure, renal failure, or congestive heart failure, was reduced by administration of perioperative sivelstat.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • liver disease which surgical management was indicated
Exclusion Criteria
  • weight loss greater than 10 per cent during the previous 6 months, signs of distant metastasis, or of respiratory, renal or heart disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
2sivelstat250mL of 5% glucose plus 300mg of sivelstat was infected through the vein at 10mL per an hour
1glucose250mL of 5% glucose was injected though the vein at 10mL per an hour
Primary Outcome Measures
NameTimeMethod
The incidence of liver damage due to reperfusion injury by Pringle maneuver was measured by several cytokines, including IL-8, IL-6, and HMGB-1.during hospitalization
Secondary Outcome Measures
NameTimeMethod
The duration of ICU stay and hospital stay, postoperative complications, and the liver damage at 6 POD, measuring hepato-biliary enzymeduring hospitalization

Trial Locations

Locations (1)

Kochi Medical School

🇯🇵

Kohasu-Okocho, Nankoku, Japan

© Copyright 2025. All Rights Reserved by MedPath